Skip to main content
Clinical Trials/CTRI/2023/01/048957
CTRI/2023/01/048957
Not yet recruiting
未知

Implementation and Evaluation of Medication Therapy Management in Patients with Hypertension

ot applicable0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
ot applicable
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Hypertensive patients with comorbidities and with polypharmacy (more than 5 drugs)

Exclusion Criteria

  • Patients with psychological illness or altered sensorium and those who are not willing to participate in the study

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Study of the benefits of Medication Therapy Management in people with long term diseasesHealth Condition 1: I259- Chronic ischemic heart disease, unspecifiedHealth Condition 2: I10- Essential (primary) hypertensionHealth Condition 3: J453- Mild persistent asthmaHealth Condition 4: J41- Simple and mucopurulent chronic bronchitisHealth Condition 5: E118- Type 2 diabetes mellitus with unspecified complications
CTRI/2022/02/040445Sapna K Dongre
Not yet recruiting
Phase 2
Clinical management of maantha sanni(Autism spectrum disorder)with maantha sanni thylam(Internal&External)Health Condition 1: null- 1 Poor eye contact 2 Mild aggresive behavior 3 Repetative behavior 4 Lack of communication skills
CTRI/2018/08/015287ATIONAL INSTITUTE OF SIDDHA
Not yet recruiting
Phase 2
Siddha Management for Maantha Sanni (Autism Spectrum Disorder) in ChildreHealth Condition 1: F840- Autistic disorder
CTRI/2020/07/026285ational institute of siddha
Not yet recruiting
Not Applicable
Impact of Medication Therapy Management for Chronic Kidney Disease PatientsHealth Condition 1: N189- Chronic kidney disease, unspecified
CTRI/2021/08/035807A
Recruiting
Not Applicable
on-interventional study on Therapeutic Drug Monitoring (TDM) in patients with renal cell carcinoma and on the feasibility of using Volumetric Absorptive Microsampling (VAMS) for sample collection (ON-TARGET)C64Malignant neoplasm of kidney, except renal pelvis
DRKS00025325Central European Society for Anticancer Drug Research (CESAR) e.V.80